000 01302 a2200397 4500
005 20250513151838.0
264 0 _c19981112
008 199811s 0 0 eng d
022 _a0169-5002
024 7 _a10.1016/s0169-5002(98)00014-2
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRobinson, C
245 0 0 _aSera from patients with malignant mesothelioma can contain autoantibodies.
_h[electronic resource]
260 _bLung cancer (Amsterdam, Netherlands)
_cJun 1998
300 _a175-84 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAntibodies, Neoplasm
_xblood
650 0 4 _aAntibody Specificity
650 0 4 _aAutoantibodies
_xblood
650 0 4 _aBlotting, Western
650 0 4 _aDisease Progression
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLung Neoplasms
_xblood
650 0 4 _aMale
650 0 4 _aMesothelioma
_xblood
650 0 4 _aMiddle Aged
650 0 4 _aTissue Distribution
700 1 _aRobinson, B W
700 1 _aLake, R A
773 0 _tLung cancer (Amsterdam, Netherlands)
_gvol. 20
_gno. 3
_gp. 175-84
856 4 0 _uhttps://doi.org/10.1016/s0169-5002(98)00014-2
_zAvailable from publisher's website
999 _c9698146
_d9698146